![](/assets/artwork/1x1-42817eea7ade52607a760cbee00d1495.gif)
14 min
![](/assets/artwork/1x1-42817eea7ade52607a760cbee00d1495.gif)
High-Efficacy Therapy Discontinuation vs Continuation in Patients 50 Years and Older With Nonactive MS JAMA Neurology Author Interviews
-
- Medicine
Interview with Anne Kerbrat, MD, PhD, author of High-Efficacy Therapy Discontinuation vs Continuation in Patients 50 Years and Older With Nonactive MS. Hosted by Cynthia E. Armand, MD.
Related Content:
High-Efficacy Therapy Discontinuation vs Continuation in Patients 50 Years and Older With Nonactive MS
Interview with Anne Kerbrat, MD, PhD, author of High-Efficacy Therapy Discontinuation vs Continuation in Patients 50 Years and Older With Nonactive MS. Hosted by Cynthia E. Armand, MD.
Related Content:
High-Efficacy Therapy Discontinuation vs Continuation in Patients 50 Years and Older With Nonactive MS
14 min